A rat model for LGI1-related epilepsies

Human Molecular Genetics

Volumn 21, Issue 16, 2012, Pages 3546-3557

  Baulac, Stéphanie ^a   Ishida, Saeko ^c   Mashimo, Tomoji ^c   Boillot, Morgane ^a,b   Fumoto, Naohiro ^c   Kuwamura, Mitsuru ^d   Ohno, Yukihiro ^e   Takizawa, Akiko ^c   Aoto, Toshihiro ^f   Ueda, Masatsugu ^f   Ikeda, Akio ^c   LeGuern, Eric ^a,b   Takahashi, Ryosuke ^c   Serikawa, Tadao ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c KYOTO UNIVERSITY   (Japan)

^d Osaka City University   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

^f PhoenixBio   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ETHOSUXIMIDE; ETHYLNITROSOUREA; ETIRACETAM; LEUCINE RICH GLIOMA INACTIVATED 1; PHENYTOIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CELL STRAIN COS7; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EXPERIMENTAL MODEL; FEMALE; FOCAL EPILEPSY; GENE; MALE; MISSENSE MUTATION; MUTAGENESIS; NERVE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; TONIC CLONIC SEIZURE;

AMINO ACID SEQUENCE; ANIMALS; ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; EPILEPSY; EPILEPSY, REFLEX; ETHOSUXIMIDE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEURONS; PHENYTOIN; PIRACETAM; PROTEINS; RATS, MUTANT STRAINS;

EID: 84865080031     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds184     Document Type: Article

References (40)

1. Baulac, S. and Baulac, M. (2010) Advances on the genetics of Mendelian idiopathic epilepsies. Clin. Lab. Med., 30, 911-929.
2. Morante-Redolat, J.M., Gorostidi-Pagola, A., Piquer-Sirerol, S., Saenz, A., Poza, J.J., Galan, J., Gesk, S., Sarafidou, T., Mautner, V.F., Binelli, S. et al. (2002) Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum. Mol. Genet., 11, 1119-1128.
3. Kalachikov, S., Evgrafov, O., Ross, B., Winawer, M., Barker-Cummings, C., Martinelli Boneschi, F., Choi, C., Morozov, P., Das, K., Teplitskaya, E. et al. (2002) Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat. Genet., 30, 335-341.
4. Michelucci, R., Poza, J.J., Sofia, V., de Feo, M.R., Binelli, S., Bisulli, F., Scudellaro, E., Simionati, B., Zimbello, R., D'Orsi, G. et al. (2003) Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families. Epilepsia, 44, 1289-1297.
5. Winawer, M.R., Ottman, R., Hauser, W.A. and Pedley, T.A. (2000) Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology, 54, 2173-2176.
6. Michelucci, R., Pasini, E. and Nobile, C. (2009) Lateral temporal lobe epilepsies: clinical and genetic features. Epilepsia, 50, 52-54.
7. Ho, Y.Y., Ionita-Laza, I. and Ottman, R. (2012) Domain-dependent clustering and genotype-phenotype analysis of LGI1 mutations in ADPEAF. Neurology, 78, 563-568.
8. Nobile, C., Michelucci, R., Andreazza, S., Pasini, E., Tosatto, S.C. and Striano, P. (2009) LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum. Mutat., 30, 530-536.
9. Lai, M., Huijbers, M.G.M., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J.K. and Dalmau, J. (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol., 9, 776-785.
10. Irani, S.R., Alexander, S., Waters, P., Kleopa, K.A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B. and Vincent, A. (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain, 133, 2734-2748.
11. Lalic, T., Pettingill, P., Vincent, A. and Capogna, M. (2011) Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission. Epilepsia, 52, 121-131.
12. Senechal, K.R., Thaller, C. and Noebels, J.L. (2005) ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum. Mol. Genet., 14, 1613-1620.
13. Striano, P., Busolin, G., Santulli, L., Leonardi, E., Coppola, A., Vitiello, L., Rigon, L., Michelucci, R., Tosatto, S.C.E., Striano, S. et al. (2011) Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation. Neurology, 76, 1173-1176.
14. Chabrol, E., Popescu, C., Gourfinkel-An, I., Trouillard, O., Depienne, C., Senechal, K., Baulac, M., LeGuern, E. and Baulac, S. (2007) Two novel epilepsy-linked mutations leading to a loss of function of LGI1. Arch. Neurol., 64, 217-222.
15. de Bellescize, J., Boutry, N., Chabrol, E., Andre-Obadia, N., Arzimanoglou, A., Leguern, E., Baulac, S., Calender, A., Ryvlin, P. and Lesca, G. (2009) A novel three base-pair LGI1 deletion leading to loss of function in a family with autosomal dominant lateral temporal epilepsy and migraine-like episodes. Epilepsy Res., 85, 118-122.
16. Sirerol-Piquer, M.S., Ayerdi-Izquierdo, A., Morante-Redolat, J.M., Herranz-Perez, V., Favell, K., Barker, P.A. and Perez-Tur, J. (2006) The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. Hum. Mol. Genet., 15, 3436-3445.
17. Striano, P., de Falco, A., Diani, E., Bovo, G., Furlan, S., Vitiello, L., Pinardi, F., Striano, S., Michelucci, R., de Falco, F.A. et al. (2008) A novel loss-of-function LGI1 mutation linked to autosomal dominant lateral temporal epilepsy. Arch. Neurol., 65, 939-942.
18. Di Bonaventura, C., Operto, F.F., Busolin, G., Egeo, G., D'Aniello, A., Vitello, L., Smaniotto, G., Furlan, S., Diani, E., Michelucci, R. et al. (2011) Low penetrance and effect on protein secretion of LGI1 mutations causing autosomal dominant lateral temporal epilepsy. Epilepsia, 52, 1258-1264.
19. Silva, J., Wang, G. and Cowell, J.K. (2011) The temporal and spatial expression pattern of the LGI1 epilepsy predisposition gene during mouse embryonic cranial development. BMC Neurosci., 12, 43.
20. Chabrol, E., Navarro, V., Provenzano, G., Cohen, I., Dinocourt, C., Rivaud-Pechoux, S., Fricker, D., Baulac, M., Miles, R., Leguern, E. et al. (2010) Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice. Brain, 133, 2749-2762.
21. Zhou, Y.D., Lee, S., Jin, Z., Wright, M., Smith, S.E. and Anderson, M.P. (2009) Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat. Med., 15, 1208-1214.
22. Schulte, U., Thumfart, J.O., Klocker, N., Sailer, C.A., Bildl, W., Biniossek, M., Dehn, D., Deller, T., Eble, S., Abbass, K. et al. (2006) The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron, 49, 697-706.
23. Fukata, Y., Adesnik, H., Iwanaga, T., Bredt, D.S., Nicoll, R.A. and Fukata, M. (2006) Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science, 313, 1792-1795.
24. Sagane, K., Ishihama, Y. and Sugimoto, H. (2008) LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11. Int. J. Biol. Sci., 4, 387-396.
25. Thomas, R., Favell, K., Morante-Redolat, J., Pool, M., Kent, C., Wright, M., Daignault, K., Ferraro, G.B., Montcalm, S., Durocher, Y. et al. (2010) LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition. J. Neurosci., 30, 6607-6612.
26. Fukata, Y., Lovero, K.L., Iwanaga, T., Watanabe, A., Yokoi, N., Tabuchi, K., Shigemoto, R., Nicoll, R.A. and Fukata, M. (2010) Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc. Natl Acad. Sci. USA, 107, 3799-3804.
27. Yu, Y.E., Wen, L., Silva, J., Li, Z., Head, K., Sossey-Alaoui, K., Pao, A., Mei, L. and Cowell, J.K. (2010) Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability. Hum. Mol. Genet., 19, 1702-1711.
28. Zhou, Y.D., Zhang, D., Ozkaynak, E., Wang, X., Kasper, E.M., Leguern, E., Baulac, S. and Anderson, M.P. (2012) Epilepsy gene LGI1 regulates postnatal developmental remodeling of retinogeniculate synapses. J. Neurosci., 32, 903-910.
29. Mashimo, T., Yanagihara, K., Tokuda, S., Voigt, B., Takizawa, A., Nakajima, R., Kato, M., Hirabayashi, M., Kuramoto, T. and Serikawa, T. (2008) An ENU-induced mutant archive for gene targeting in rats. Nat. Genet., 40, 514-515.
30. Ross, K.C. and Coleman, J.R. (2000) Developmental and genetic audiogenic seizure models: behavior and biological substrates. Neurosci. Biobehav. Rev., 24, 639-653.
31. Leonardi, E., Andreazza, S., Vanin, S., Busolin, G., Nobile, C. and Tosatto, S.C.E. (2011) A computational model of the LGI1 protein suggests a common binding site for ADAM proteins. PLoS One, 6, e18142.
32. Owuor, K., Harel, N.Y., Englot, D.J., Hisama, F., Blumenfeld, H. and Strittmatter, S.M. (2009) LGI1-associated epilepsy through alteredADAM23-dependent neuronal morphology. Mol. Cell. Neurosci., 42, 448-457.
33. Lynch, B.A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S.M., Matagne, A. and Fuks, B. (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl Acad. Sci. USA, 101, 9861-9866.
34. Kaminski, R.M., Gillard, M., Leclercq, K., Hanon, E., Lorent, G., Dassesse, D., Matagne, A. and Klitgaard, H. (2009) Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam. Epilepsia, 50, 1729-1740.
35. Kunapuli, P., Jang, G.F., Kazim, L. and Cowell, J.K. (2009) Mass spectrometry identifies LGI1-interacting proteins that are involved in synaptic vesicle function in the human brain. J. Mol. Neurosci., 39, 137-143.
36. McCutcheon, J.E. and Marinelli, M. (2009) Age matters. Eur. J. Neurosci., 29, 997-1014.
37. Sagane, K., Hayakawa, K., Kai, J., Hirohashi, T., Takahashi, E., Miyamoto, N., Ino, M., Oki, T., Yamazaki, K. and Nagasu, T. (2005) Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice. BMC Neurosci., 6, 33.
38. Smart, S.L., Lopantsev, V., Zhang, C.L., Robbins, C.A., Wang, H., Chiu, S.Y., Schwartzkroin, P.A., Messing, A. and Tempel, B.L. (1998) Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron, 20, 809-819.
39. Yu, F.H., Mantegazza, M., Westenbroek, R.E., Robbins, C.A., Kalume, F., Burton, K.A., Spain, W.J., McKnight, G.S., Scheuer, T. and Catterall, W.A. (2006) Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci., 9, 1142-1149.
40. Ross, K.C. and Coleman, J.R. (1999) Audiogenic seizures in the developmentally primed Long-Evans rat. Dev. Psychobiol., 34, 303-313.